<SEC-DOCUMENT>0000799698-16-000049-index.html : 20161129 <SEC-HEADER>0000799698-16-000049.hdr.sgml : 20161129 <ACCEPTANCE-DATETIME>20161128185927 ACCESSION NUMBER: 0000799698-16-000049 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20161129 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20161129 DATE AS OF CHANGE: 20161128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CYTRX CORP CENTRAL INDEX KEY: 0000799698 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 581642750 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-15327 FILM NUMBER: 162021011 BUSINESS ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 BUSINESS PHONE: 310-826-5648 MAIL ADDRESS: STREET 1: 11726 SAN VICENTE BOULEVARD STREET 2: SUITE 650 CITY: LOS ANGELES STATE: CA ZIP: 90049 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>form8k.htm <DESCRIPTION>DISCLOSURE OF PRESS RELEASE ANNOUNCING PHASE III TRIAL ANALYSES <TEXT> Document 1 - file: form8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>exh99_1.htm <DESCRIPTION>PRESS RELEASE DATED NOVEMBER 29, 2016 <TEXT> Document 2 - file: exh99_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>image00001.jpg <TEXT> Document 3 - file: image00001.jpg
</DOCUMENT> </SEC-DOCUMENT>